Fluid biomarkers in Alzheimer’s disease – current concepts

The diagnostic guidelines of Alzheimer’s disease (AD) have recently been updated to include brain imaging and cerebrospinal fluid (CSF) biomarkers, with the aim of increasing the certainty of whether a patient has an ongoing AD neuropathologic process or not. The CSF biomarkers total tau (T-tau), hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosén, Christoffer, Hansson, Oskar, Blennow, Kaj, Zetterberg, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691925/
https://www.ncbi.nlm.nih.gov/pubmed/23800368
http://dx.doi.org/10.1186/1750-1326-8-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691925/
https://www.ncbi.nlm.nih.gov/pubmed/23800368
http://dx.doi.org/10.1186/1750-1326-8-20

Ejemplares similares